Target intelligence / Profile preview

Immunoglobulin lambda variable 1-51 (IGLV1-51)

Target
IGLV1-51
Molecular classification
Immunoglobulin variable domain, Other (immunoglobulin gene segment)
01

Overview

Immunoglobulin lambda variable 1-51 (IGLV1-51) encodes the variable region of the lambda light chain found in immunoglobulin molecules, also known as antibodies[1][2][4][7][8]. This variable region participates directly in antigen binding, constituting one half of the antibody’s antigen-binding site, with the other half provided by the heavy chain variable region[1][4][7]. In B lymphocytes, the assembly of various V (variable), J (joining), and C (constant) gene segments generates the diversity required for the immune system to recognize a vast array of antigens[3][5]. IGLV1-51 is not a typical pharmacological target, as its principal biological role is as a segment used in immunoglobulin gene rearrangement, contributing to antibody diversity and the adaptive immune response. Mutations or rearrangements in these gene segments can be found in B cell malignancies, and their immunoglobulin gene rearrangements may be used for clonality assessment in clinical diagnostics, but not as direct therapeutic targets[1][3][5].

Other names
Ig lambda chain V-I region BL2Ig lambda chain V-I region EPSIg lambda chain V-I region NEWIg lambda chain V-I region NIG-64IGLV151V1-19Ig lambda chain V-I region 51
02

Biological functions

Antigen recognitionImmune response
03

Disease associations

Other (involved in antibody diversity and immune defense, but not itself a direct disease driver)

Beyond the preview

Go deeper on Immunoglobulin lambda variable 1-51 (IGLV1-51).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 1-51 (IGLV1-51).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call